Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stressful life events and depression onset: A longitudinal investigation of depression course subtypes.

Journal of psychopathology and clinical science·2026
Same author

The development and course of youth psychopathology: a longitudinal study of prevalence and continuity from early childhood through late adolescence.

European child & adolescent psychiatry·2026
Same author

Impact of Parent Lifetime Depression and Anxiety on Youth Body Dissatisfaction and Disordered Eating Symptoms During Adolescence.

Behavior therapy·2026
Same author

Inhibitory control mediates the association between perinatal PM2.5 exposure and childhood obesity in children in the PROGRESS cohort, Mexico City.

Communications medicine·2026
Same author

Associations of Tonic and Phasic Irritability With Psychopathology Subfactors of the Hierarchical Taxonomy of Psychopathology.

Clinical psychological science : a journal of the Association for Psychological Science·2026
Same author

Are there differences in depression across biological sex and developmental phases? Examining the structure and measurement invariance of depressive symptoms in males and females from childhood through adolescence.

Journal of psychopathology and clinical science·2026

Related Experiment Video

Updated: Jun 22, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Chronic depression: update on classification and treatment.

Dana C Torpey1, Daniel N Klein

  • 1Department of Psychology, Stony Brook University, Stony Brook, NY 11794-2500, USA. daniel.klein@stonybrook.edu

Current Psychiatry Reports
|November 5, 2008
PubMed
Summary
This summary is machine-generated.

Chronic depression affects many patients and differs from major depressive disorder (MDD). While treatments exist, further research is needed to understand its causes and personalize therapies for better outcomes.

More Related Videos

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 22, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Animal Models of Depression - Chronic Despair Model (CDM)
05:47

Animal Models of Depression - Chronic Despair Model (CDM)

Published on: September 23, 2021

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Neuroscience

Background:

  • A significant number of individuals with depressive disorders experience chronic conditions.
  • Chronic depression is recognized by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), with distinct clinical, psychosocial, and familial characteristics compared to nonchronic major depressive disorder (MDD).
  • Current distinctions between various forms of chronic depression lack substantial empirical support.

Purpose of the Study:

  • To review the characteristics and treatment of chronic depression.
  • To highlight the efficacy of combined pharmacotherapy and psychotherapy.
  • To identify future research directions for understanding and treating chronic depression.

Main Methods:

  • Literature review of studies on chronic depression.
  • Analysis of clinical, psychosocial, and familial variables differentiating chronic from nonchronic MDD.
  • Evaluation of treatment efficacies for chronic depression.

Main Results:

  • Chronic depression presents unique clinical, psychosocial, and familial profiles compared to nonchronic MDD.
  • Both antidepressant medications and psychotherapy are effective for chronic depression.
  • Combination therapy (pharmacotherapy and psychotherapy) shows superiority over monotherapy.

Conclusions:

  • Chronic depression is a distinct condition requiring tailored treatment approaches.
  • Despite treatment advancements, many patients experience inadequate response or residual symptoms.
  • Future research should focus on elucidating the diverse pathways to chronic depression and developing personalized treatment strategies for specific etiopathogenetic subgroups.